Claire Elizabeth Smith

Claire Elizabeth Smith is a Partner at SpringTide Ventures, a healthcare and tech-bio focused venture capital firm.23 She joined SpringTide in September 2023 and was promoted to Partner in May 2024.12

Claire has extensive experience in healthcare and life sciences investing:

1. Prior to SpringTide, she was a Principal at Meridian Street Capital, focusing on seed-stage health tech investments.23
2. She also worked as a Senior Associate at Anterra Capital, where she focused on biotech and agriculture investments.23
3. Claire served as Chief of Staff at Crestovo, a microbiome therapeutics startup that was later acquired by Finch Therapeutics.23
4. She began her career as a Consultant at ClearView Healthcare Partners, advising pharma and biotech clients.23

Claire's educational background includes:

• Bachelor's degrees in Biological Engineering and Management Science from the Massachusetts Institute of Technology (MIT).23

In her role at SpringTide, Claire is involved in capital formation, deal-making, and portfolio governance.1 She currently serves on the board of Leash Labs and is a board observer at IgniteData and Paterna Biosciences.3

Claire's investment focus at SpringTide Ventures ranges from $100K to $5.0M, with a sweet spot of $1.5M.4